GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mach7 Technologies Ltd (ASX:M7T) » Definitions » EBITDA Margin %

Mach7 Technologies (ASX:M7T) EBITDA Margin % : -15.92% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Mach7 Technologies EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Mach7 Technologies's EBITDA for the six months ended in Dec. 2023 was A$-2.12 Mil. Mach7 Technologies's Revenue for the six months ended in Dec. 2023 was A$13.33 Mil. Therefore, Mach7 Technologies's EBITDA margin for the quarter that ended in Dec. 2023 was -15.92%.


Mach7 Technologies EBITDA Margin % Historical Data

The historical data trend for Mach7 Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mach7 Technologies EBITDA Margin % Chart

Mach7 Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43.54 17.57 -9.60 15.03 -41.89

Mach7 Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.29 -5.99 19.75 -304.99 -15.92

Competitive Comparison of Mach7 Technologies's EBITDA Margin %

For the Health Information Services subindustry, Mach7 Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mach7 Technologies's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Mach7 Technologies's EBITDA Margin % falls into.



Mach7 Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Mach7 Technologies's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-8.486/20.258
=-41.89 %

Mach7 Technologies's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-2.123/13.332
=-15.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mach7 Technologies  (ASX:M7T) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Mach7 Technologies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Mach7 Technologies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mach7 Technologies (ASX:M7T) Business Description

Traded in Other Exchanges
N/A
Address
120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403
Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialisation of medical imaging and data, management software solutions for global healthcare enterprises The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.

Mach7 Technologies (ASX:M7T) Headlines

No Headlines